Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:NBRV
Tag: NASDAQ:NBRV
NABRIVA THERAPEUTICS AG (NASDAQ:NBRV) Files An 8-K Changes in Registrant’s Certifying...
ME Staff 8-k
-
May 31, 2017
0
NABRIVA THERAPEUTICS AG (NASDAQ:NBRV) Files An 8-K Other Events
ME Staff 8-k
-
May 23, 2017
0
NABRIVA THERAPEUTICS AG (NASDAQ:NBRV) Files An 8-K Results of Operations and...
ME Staff 8-k
-
May 12, 2017
0
NABRIVA THERAPEUTICS AG (NASDAQ:NBRV) Files An 8-K Results of Operations and...
ME Staff 8-k
-
May 10, 2017
0
NABRIVA THERAPEUTICS AG (NASDAQ:NBRV) Files An 8-K Other Events
ME Staff 8-k
-
April 18, 2017
0
NABRIVA THERAPEUTICS AG (NASDAQ:NBRV) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
April 5, 2017
0
NABRIVA THERAPEUTICS AG (NASDAQ:NBRV) Files An 8-K Results of Operations and...
ME Staff 8-k
-
March 24, 2017
0
NABRIVA THERAPEUTICS AG (NASDAQ:NBRV) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
February 14, 2017
0
NABRIVA THERAPEUTICS AG (NASDAQ:NBRV) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
January 9, 2017
0
Nabriva Therapeutics (NASDAQ:NBRV) Initiates 2nd Phase III Trials of Lefamulin
-
April 15, 2016
0
1
2
Page 2 of 2
